Drug treatment commissioning and market mechanisms with Alison Ritter
Addiction Audio · Rob Calder
Audio is streamed directly from the publisher (sphinx.acast.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
Professor Alison Ritter talks about her recent paper “Are market mechanisms associated with alcohol and other drug treatment outcomes” and about the Australian context of drug treatment provision and commissioning. We discuss the challenges of measuring outcomes against commissioning structures and Professor Ritter explains how funding arrangements can end up looking like a bowl of spaghetti. Alison discusses why governments don’t necessarily have to tender competitively, about the burdens associated with the machinery of recommissioning and about the potential for fixed-price tendering to improve the quality of addiction treatment services.
Ritter, A., van de Ven, K., Vuong, T., Chalmers, J., Dobbins, T., Livingston, M. and Berends, L. Are market mechanisms associated with alcohol and other drug treatment outcomes?. Addiction 2021; doi:10.1111/add.15681
https://onlinelibrary.wiley.com/doi/10.1111/add.15681
Hosted on Acast. See acast.com/privacy for more information.